AlphaFold predicted structure
DYNC2LI1 · Q8TCX1

Mean pLDDT
85.1/ 100
Confident
351 residues
Confidence breakdown
- Very high(≥ 90)53%
- Confident(70–90)32%
- Low(50–70)11%
- Very low(< 50)3%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
dynein cytoplasmic 2 light intermediate chain 1
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Clefting
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalRare multisystem ciliopathy disorders
BIALLELIC, autosomal or pseudoautosomalSkeletal ciliopathies
BIALLELIC, autosomal or pseudoautosomalSkeletal dysplasia
BIALLELIC, autosomal or pseudoautosomalThoracic dystrophies
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
+2 more panels — install the extension to see the full list inline on any page.
Ellis Van Creveld syndrome
Jeune syndrome
short rib-polydactyly syndrome
cholelithiasis
Ellis-van Creveld syndrome
gallstones
Cholecystitis
liver disorder
digestive system disorder
gallbladder disorder
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Cytoplasmic dynein 2 light intermediate chain 1
Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 2 complex (dynein-2 complex), a motor protein complex that drives the movement of cargos along microtubules within cilia and flagella in concert with the intraflagellar transport (IFT) system, facilitating the assembly of these organelles (PubMed:29742051). Involved in the regulation of ciliary length (PubMed:26077881, PubMed:26130459)
DYNC2LI1 · Q8TCX1

Mean pLDDT
85.1/ 100
Confident
351 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0